Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2021 Financial Results and Host Webcast on March 1, 2022

Rhea-AI Summary

Horizon Therapeutics plc (Nasdaq: HZNP) is set to announce its fourth-quarter and full-year 2021 financial results on March 1, 2022, at 8 a.m. Eastern Time. Following this, the management will host a live webcast to discuss the financial and operational outcomes. Interested parties can access the live webcast and replay via the company’s investor relations website. Horizon focuses on developing therapies for rare, autoimmune, and severe inflammatory diseases, aiming to address critical patient needs.

Positive

• Scheduled release of Q4 and full-year 2021 financial results that could indicate strong performance.
• Live webcast helps maintain transparency with investors.

Negative

• None.

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its fourth-quarter and full-year 2021 financial results on Tuesday, March 1, 2022. Following the announcement, Horizon’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.

The live webcast and a replay may be accessed at http://ir.horizontherapeutics.com. Please connect to the Company’s website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. A replay of the webcast will be available approximately two hours after the live webcast.

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220207005152/en/

Horizon contacts:

Tina Ventura

Senior Vice President, Chief Investor Relations Officer

Investor-relations@horizontherapeutics.com

U.S. Media Contacts:

Geoff Curtis

Executive Vice President, Corporate Affairs & Chief Communications Officer

media@horizontherapeutics.com

Ireland Media Contact:

Gordon MRM

Ray Gordon

ray@gordonmrm.ie

Source: Horizon Therapeutics plc

FAQ

When will Horizon Therapeutics announce its financial results?

Horizon Therapeutics will announce its financial results on March 1, 2022.

What time is the Horizon Therapeutics financial results webcast?

The webcast will begin at 8 a.m. Eastern Time.

How can I access the Horizon Therapeutics financial results webcast?

The webcast can be accessed through Horizon's investor relations website.

What is Horizon Therapeutics focused on?

Horizon Therapeutics focuses on medicines for rare, autoimmune, and severe inflammatory diseases.